Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Wayne AS, Huynh V, Hijiya N, Rouce RH, et al. Haematologica 2023;108:747-760.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wayne AS, Huynh V, Hijiya N, Rouce RH, et al. Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica 2023;108:747-760.
PMID: 36263840